Lead analysis and interpretation of cancer's molecular signatures, guiding model development for biological changes.
Execute rigorous computational analyses on data from high-throughput molecular assays including sequencing and protein quantitation.
Partner with molecular biologists and development scientists to refine experiments and turn research models into products.
Freenome is a biotechnology company developing blood tests for early cancer detection. We are a growing organization dedicated to changing the landscape of cancer, with a collaborative and diverse team.
Own CMC oversight across every active asset, ensuring on-time and on-budget delivery of drug substance, drug product, analytics, stability, and regulatory filings.
Select, contract, and manage CDMOs and external partners, holding them to timelines, quality, and cost.
Scope and de-risk the CMC of inherited in-licensing candidates, flagging manufacturing complexity or cost that could affect asset viability.
Our mission is to fix the broken clinical-stage biopharma model by in-licensing therapeutic assets and developing them through integrated, technology-first clinical trial infrastructure. We are a new initiative built on a proven foundation, with a team that has delivered 40+ trials across the US and Europe, and we are a high-growth, mission-driven, VC-funded startup.
Provide technical leadership in genomic surveillance, analytics, and antimicrobial resistance for global health security initiatives in Sierra Leone.
Support strengthening of detection capacity and laboratory systems for human and animal health networks.
Contribute to design, implementation, and monitoring of strategies aligned with global best practices and national policies.
PSI is a globally connected organization working to achieve consumer-powered healthcare, focusing on people-centered health systems. With over 50 years of experience, it has developed innovative solutions to complex global health challenges and operates as a network of locally rooted entities.
Lead clinical trial strategies and evidence-generation initiatives for diagnostic product development and regulatory submissions.
Serve as a scientific expert guiding study design, interpreting clinical data, and collaborating with stakeholders.
Ensure successful clinical programs across US and EU markets, ensuring scientific rigor and regulatory alignment.
The company develops innovative diagnostic solutions. They foster a collaborative environment emphasizing scientific excellence, continuous learning, and impactful solutions.
Provide strategic leadership and medical expertise for clinical development of antibody portfolio in IBD.
Lead ongoing Phase 2 platform study and shape registrational program.
Drive cross-functional collaboration and regulatory interactions for global submissions.
Spyre Therapeutics is a clinical-stage biotechnology company developing next-generation therapies for immunology. It is a young, fast-paced company with a high-growth environment, focused on advancing antibody therapeutics for IBD.
Lead and manage a team of MSLs across the West region, coordinating medical and scientific liaison activities with internal and external stakeholders.
Develop and execute comprehensive territory medical plans, foster relationships with key opinion leaders, and ensure high-quality scientific exchange.
Recruit, train, and develop high-performing MSLs, and contribute to product development strategy and launch planning.
BridgeBio is a biopharmaceutical company that uses a pooled project model to reduce risk and accelerate development of life-changing medicines for rare diseases. They foster a culture of curiosity and experimentation with small teams of experts and a focus on innovation.